Abstract:Motivation: With the booming of interactome studies, a lot of interactions can be measured in a high throughput way and large scale datasets are available. It is becoming apparent that many different types of interactions can be potential drug targets. Compared with inhibition of a single protein, inhibition of protein-protein interaction (PPI) is promising to improve the specificity with fewer adverse side-effects. Also it greatly broadens the drug target search space, which makes the drug target discovery difficult. Computational methods are highly desired to efficiently provide candidates for further experiments and hold the promise to greatly accelerate the discovery of novel drug targets.Results: Here, we propose a machine learning method to predict PPI targets in a genomic-wide scale. Specifically, we develop a computational method, named as PrePPItar, to Predict PPIs as drug targets by uncovering the potential associations between drugs and PPIs. First, we survey the databases and manually construct a gold-standard positive dataset for drug and PPI interactions. This effort leads to a dataset with 227 associations among 63 PPIs and 113 FDA-approved drugs and allows us to build models to learn the association rules from the data. Second, we characterize drugs by profiling in chemical structure, drug ATC-code annotation, and side-effect space and represent PPI similarity by a symmetrical S-kernel based on protein amino acid sequence. Then the drugs and PPIs are correlated by Kronecker product kernel. Finally, a support vector machine (SVM), is trained to predict novel associations between drugs and PPIs. We validate our PrePPItar method on the well-established gold-standard dataset by cross-validation. We find that all chemical structure, drug ATC-code, and side-effect information are predictive for PPI target. Moreover, we can increase the PPI target prediction coverage by integrating multiple data sources. Follow-up database search and pathway analysis indicate that our new predictions are worthy of future experimental validation.Conclusion: In conclusion, PrePPItar can serve as a useful tool for PPI target discovery and provides a general heterogeneous data integrative framework.

Genome-Scale Screening Of Drug-Target Associations Relevant To K-I Using A Chemogenomics Approach

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Predicting Drug-Target Interactions Between New Drugs and New Targets via Pairwise K-nearest Neighbor and Automatic Similarity Selection.

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

Computational Probing Protein-Protein Interactions Targeting Small Molecules.

Sdtnbi: an Integrated Network and Chemoinformatics Tool for Systematic Prediction of Drug-Target Interactions and Drug Repositioning

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity

Large-scale Prediction of Human Kinase-Inhibitor Interactions Using Protein Sequences and Molecular Topological Structures.

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

BioDKG-DDI: Predicting Drug-Drug Interactions Based on Drug Knowledge Graph Fusing Biochemical Information.

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features.

Incorporating Chemical Sub-Structures and Protein Evolutionary Information for Inferring Drug-Target Interactions

Prediction of Chemical-Protein Interactions: Multitarget-Qsar Versus Computational Chemogenomic Methods

Prediction of Effective Drug Combinations by Chemical Interaction, Protein Interaction and Target Enrichment of KEGG Pathways

Large-scale Prediction of Drug–target Interactions Using Protein Sequences and Drug Topological Structures

A Computational Approach For Predicting Drug-Target Interactions From Protein Sequence And Drug Substructure Fingerprint Information

DTKGIN: Predicting Drug-Target Interactions Based on Knowledge Graph and Intent Graph

Pred-binding: large-scale protein–ligand binding affinity prediction